Pedro Rodrigues Genta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pedro Rodrigues Genta has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Geraldo Lorenzi-Filho
Universidade de São Paulo
18 shared publications Geraldo Lorenzi-Filho
9 shared publications- Luciano Ferreira Drager
Hypertension Unit, Heart Institute (InCor), University of São Paulo, São Paulo, Brazil; Hypertension Unit, Renal Division, University of São Paulo, São Paulo, Brazil
7 shared publications - Rafael Stelmach
Divisão de Pneumologia, Instituto do Coração - InCor - Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil
4 shared publications - Ascedio José Rodrigues
Department of Lung Transplantation, Instituto do Coração - InCor, Heart Institute - University of São Paulo, São Paulo, Brazil
3 shared publications - Eduardo Leite Vieira Costa
Pulmonary Division, Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brazil
3 shared publications
Latest Publications
- 15 October 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (9) , 1374-1377
Longitudinal Changes in Body Composition and OSA Severity among Older Men: The MrOS Study
- 15 October 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (9) , 1374-1377
Longitudinal Changes in Body Composition and OSA Severity among Older Men: The MrOS Study
- 30 September 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (3) , 429-437
Acute effect of continuous positive airway pressure on weight in patients with obstructive sleep apnea: a randomized study
Rationale: Continuous positive airway pressure (CPAP) may lead to weight gain in patients with obstructive sleep apnea (OSA), but the mechanisms are still unclear. Objectives: To investigate the effects of the first night of CPAP therapy on body weight and nocturnal urine output in treatment-naïve patients with severe OSA. Methods: The study was conducted during 2 consecutive nights. During the first night, a baseline polysomnography (PSG) was performed. Weight, urinary parameters, and body composition change during baseline PSG were compared to the second PSG, which was randomized to either CPAP titration or repeat PSG without any intervention (Control group). Body weight and bioelectric impedance were assessed in the evening before bedtime and in the morning, after voiding. Overnight urinary volume and osmolality, antidiuretic hormone, and type-B natriuretic peptide (BNP) were determined in the morning after each PSG. Results: Thirty-eight patients (60% men; aged 54 ± 9 years; body mass index: 35.0 ± 6.2 kg/m2; apnea-hypopnea index: 71 ± 25 events/h) completed the study (n = 19 per group). CPAP led to a significant increase in body weight (0.37 ± 0.55 kg) compared to the Control group (−0.30 ± 0.46 kg), P < 0.001. Urinary volume remained stable between Visits 1 (873 ± 537 mL) and 2 (915 ± 517 mL) (P > 0.999) but reduced significantly in the CPAP group from 825 ± 389 to 556 ± 334 mL, respectively, P < 0.001. Urinary osmolality remained stable between Visits 1 (575 ± 221 mOsm/kg) and 2 (523 ± 225 mOsm/kg) (P = 0.756) in the Control group, but increased in the CPAP group from 629 ± 183 to 746 ± 154 mOsm/kg, respectively, P = 0.005. While total body water reduced overnight in the Control group, CPAP significantly attenuated the overnight reduction in total body water (P < 0.001). No significant changes in antidiuretic hormone and BNP were observed. Conclusion: CPAP led to weight gain and fluid accumulation after a single night. These findings provide strong evidence that fluid accumulation is involved in weight gain associated with OSA treatment with CPAP. Trial registration: ClinicalTrials.gov; No.: NCT05253963; URL: www.clinicaltrials.gov
- 30 September 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (3) , 429-437
Acute effect of continuous positive airway pressure on weight in patients with obstructive sleep apnea: a randomized study
Rationale: Continuous positive airway pressure (CPAP) may lead to weight gain in patients with obstructive sleep apnea (OSA), but the mechanisms are still unclear. Objectives: To investigate the effects of the first night of CPAP therapy on body weight and nocturnal urine output in treatment-naïve patients with severe OSA. Methods: The study was conducted during 2 consecutive nights. During the first night, a baseline polysomnography (PSG) was performed. Weight, urinary parameters, and body composition change during baseline PSG were compared to the second PSG, which was randomized to either CPAP titration or repeat PSG without any intervention (Control group). Body weight and bioelectric impedance were assessed in the evening before bedtime and in the morning, after voiding. Overnight urinary volume and osmolality, antidiuretic hormone, and type-B natriuretic peptide (BNP) were determined in the morning after each PSG. Results: Thirty-eight patients (60% men; aged 54 ± 9 years; body mass index: 35.0 ± 6.2 kg/m2; apnea-hypopnea index: 71 ± 25 events/h) completed the study (n = 19 per group). CPAP led to a significant increase in body weight (0.37 ± 0.55 kg) compared to the Control group (−0.30 ± 0.46 kg), P < 0.001. Urinary volume remained stable between Visits 1 (873 ± 537 mL) and 2 (915 ± 517 mL) (P > 0.999) but reduced significantly in the CPAP group from 825 ± 389 to 556 ± 334 mL, respectively, P < 0.001. Urinary osmolality remained stable between Visits 1 (575 ± 221 mOsm/kg) and 2 (523 ± 225 mOsm/kg) (P = 0.756) in the Control group, but increased in the CPAP group from 629 ± 183 to 746 ± 154 mOsm/kg, respectively, P = 0.005. While total body water reduced overnight in the Control group, CPAP significantly attenuated the overnight reduction in total body water (P < 0.001). No significant changes in antidiuretic hormone and BNP were observed. Conclusion: CPAP led to weight gain and fluid accumulation after a single night. These findings provide strong evidence that fluid accumulation is involved in weight gain associated with OSA treatment with CPAP. Trial registration: ClinicalTrials.gov; No.: NCT05253963; URL: www.clinicaltrials.gov
- 1 March 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (3) , 430-437
Mouth Leak Is Associated with Sleep Fragmentation During Nasal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea and May Be Detected by Leak Waveform Analysis
Rationale: Mouth air leak is a major cause of low adherence to nasal continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). However, CPAP reports do not distinguish mouth leak from mask leak. We hypothesized that mouth air leak is terminated abruptly by an arousal from sleep and mouth closing that can be detected by CPAP leak waveform analysis. Objectives: To describe patterns of mouth air leak waveform during polysomnography (PSG) in patients with OSA treated with well-fitted nasal CPAP. Methods: PSG recordings with a jaw motion sensor to detect mouth opening were performed in patients with OSA treated with nasal CPAP with suspected mouth air leak. Careful mask fitting and visual inspection excluded mask leak. Mouth leak episodes were characterized by an increase (⩾20%) above the intentional leak. Leak episodes were classified as intermittent (<5 minutes) or continuous (⩾5 minutes). Results: Twenty patients (80% men; age, 63 ± 11 years; body mass index, 29.9 ± 6 kg/m2; baseline apnea–hypopnea index, 46.9 ± 19 events per hour) treated with nasal CPAP and documented mouth leak completed the study. All but one patient experienced an overlap of intermittent and continuous mouth leak. Most mouth leak episodes ended with mouth closure (97.7%) and an arousal (52.7%) or awakening (38.6%). Only 34.9% of the leak episodes were associated with respiratory events. Intermittent mouth air leak was more common in sleep stages N1 and N2 (P < 0.01), whereas continuous leak was more common in sleep stage N3 (P < 0.01). Continuous episodes of air leak were associated with a higher amplitude of mouth opening. The CPAP report waveform was able to detect only 29.6% of the leak episodes detected by PSG. Only 10 patients (50%) had a high unintentional leak according to the criteria adopted by ResMed, and only 2 patients (10%) presented large leak according to the Philips criteria. Conclusions: Intermittent and continuous mouth leak during nasal CPAP frequently coexist and contribute to sleep fragmentation. Identification of leak waveform patterns may help detect mouth air leak, which, in turn, is an important cause of poor CPAP adherence.
- 1 March 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (3) , 430-437
Mouth Leak Is Associated with Sleep Fragmentation During Nasal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea and May Be Detected by Leak Waveform Analysis
Rationale: Mouth air leak is a major cause of low adherence to nasal continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). However, CPAP reports do not distinguish mouth leak from mask leak. We hypothesized that mouth air leak is terminated abruptly by an arousal from sleep and mouth closing that can be detected by CPAP leak waveform analysis. Objectives: To describe patterns of mouth air leak waveform during polysomnography (PSG) in patients with OSA treated with well-fitted nasal CPAP. Methods: PSG recordings with a jaw motion sensor to detect mouth opening were performed in patients with OSA treated with nasal CPAP with suspected mouth air leak. Careful mask fitting and visual inspection excluded mask leak. Mouth leak episodes were characterized by an increase (⩾20%) above the intentional leak. Leak episodes were classified as intermittent (<5 minutes) or continuous (⩾5 minutes). Results: Twenty patients (80% men; age, 63 ± 11 years; body mass index, 29.9 ± 6 kg/m2; baseline apnea–hypopnea index, 46.9 ± 19 events per hour) treated with nasal CPAP and documented mouth leak completed the study. All but one patient experienced an overlap of intermittent and continuous mouth leak. Most mouth leak episodes ended with mouth closure (97.7%) and an arousal (52.7%) or awakening (38.6%). Only 34.9% of the leak episodes were associated with respiratory events. Intermittent mouth air leak was more common in sleep stages N1 and N2 (P < 0.01), whereas continuous leak was more common in sleep stage N3 (P < 0.01). Continuous episodes of air leak were associated with a higher amplitude of mouth opening. The CPAP report waveform was able to detect only 29.6% of the leak episodes detected by PSG. Only 10 patients (50%) had a high unintentional leak according to the criteria adopted by ResMed, and only 2 patients (10%) presented large leak according to the Philips criteria. Conclusions: Intermittent and continuous mouth leak during nasal CPAP frequently coexist and contribute to sleep fragmentation. Identification of leak waveform patterns may help detect mouth air leak, which, in turn, is an important cause of poor CPAP adherence.
- Open Access
- 1 January 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (1) , 41-42
Time to Change: The Effect of Mask Switching on Continuous Positive Airway Pressure Adherence
- 1 January 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (1) , 41-42
Open AccessTime to Change: The Effect of Mask Switching on Continuous Positive Airway Pressure Adherence
- Open Access
- 11 November 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (5) , e20240356
Understanding the link between interstitial lung disease and obstructive sleep apnea: is lung volume involved?
- 11 November 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (5) , e20240356
Open AccessUnderstanding the link between interstitial lung disease and obstructive sleep apnea: is lung volume involved?
- Open Access
- 24 October 2024
- Published by Taylor & Francis in Pulmonology
- Vol. 31 (1)
Impact of treating obesity hypoventilation syndrome on body mass index
To evaluate the impact of positive airway pressure (PAP) therapy on body mass index (BMI) in patients with obesity hypoventilation syndrome (OHS) associated with obstructive sleep apnea (OSA). A systematic review using the following terms: "obesity hypoventilation syndrome" AND "treatment" AND "randomized" using Cochrane Central Register of Controlled Trials, Medline and Web of Science was performed from the first data available until February 10, 2023. The inclusion criteria were: (1) original article; (2) adult OHS with concomitant OSA (apnea-hypopnea index or AHI ≥5 events/h); (3) randomized trial with PAP arm and standard care (control); (4) BMI evaluation at baseline and after the first months. We performed an individual participant data meta-analysis of randomized controlled trials. Our initial search retrieved 32 articles and 3 randomized studies fulfilled study criteria and were included in the final analysis, leading to a total of 342 participants. Patients were predominantly females (62%) and had OHS associated with at least mild OSA. As compared to baseline, a decrease in BMI was observed at study endpoint but this difference was not different intergroups (-0.50 ± 1.49 and -0.50 ±1.83, in control and PAP groups respectively (p=0.939)). Weight change was not associate with PAP adherence, OSA severity or use of supplemental oxygen. In contrast to treatment of eucapnic OSA with PAP that is associated with weight gain, treatment of OSA+OHS patients with or without PAP is associated with weight loss. Future studies are necessary to elucidate the mechanism by which weight loss occurs.
- 24 October 2024
- Published by Taylor & Francis in Pulmonology
- Vol. 31 (1)
Open AccessImpact of treating obesity hypoventilation syndrome on body mass index
To evaluate the impact of positive airway pressure (PAP) therapy on body mass index (BMI) in patients with obesity hypoventilation syndrome (OHS) associated with obstructive sleep apnea (OSA). A systematic review using the following terms: "obesity hypoventilation syndrome" AND "treatment" AND "randomized" using Cochrane Central Register of Controlled Trials, Medline and Web of Science was performed from the first data available until February 10, 2023. The inclusion criteria were: (1) original article; (2) adult OHS with concomitant OSA (apnea-hypopnea index or AHI ≥5 events/h); (3) randomized trial with PAP arm and standard care (control); (4) BMI evaluation at baseline and after the first months. We performed an individual participant data meta-analysis of randomized controlled trials. Our initial search retrieved 32 articles and 3 randomized studies fulfilled study criteria and were included in the final analysis, leading to a total of 342 participants. Patients were predominantly females (62%) and had OHS associated with at least mild OSA. As compared to baseline, a decrease in BMI was observed at study endpoint but this difference was not different intergroups (-0.50 ± 1.49 and -0.50 ±1.83, in control and PAP groups respectively (p=0.939)). Weight change was not associate with PAP adherence, OSA severity or use of supplemental oxygen. In contrast to treatment of eucapnic OSA with PAP that is associated with weight gain, treatment of OSA+OHS patients with or without PAP is associated with weight loss. Future studies are necessary to elucidate the mechanism by which weight loss occurs.
- Open Access
- 29 February 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (1) , e20230351
One step forward in understanding sleep in hypersensitivity pneumonitis patients
- 29 February 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (1) , e20230351
Open AccessOne step forward in understanding sleep in hypersensitivity pneumonitis patients